HIV and hepatitis C outbreaks among high-risk youth in Vancouver demands a public health response.
This paper is a call to action. We present Kaplan Meier cumulative HIV and HCV incidence rates among youth aged < or = 24 participating in the Vancouver Injection Drug Users Study (VIDUS), and demonstrate the alarming increase in HIV and HCV incidence rates in addicted youth. The incidence rates among VIDUS youth were 11.1% for HIV and 52.1% for HCV at 36 months after enrollment in the study. The growing epidemic of HIV and HCV among addicted youth calls for policy-makers and program planners to concentrate resources into prevention and treatment of blood-borne infections among British Columbia's vulnerable youth. Without focussing such resources, further HIV and HCV infections and subsequent higher health care costs appear imminent.